Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

2.82
+0.02000.71%
Post-market: 2.840.0193+0.68%17:37 EDT
Volume:1.23M
Turnover:3.44M
Market Cap:549.90M
PE:-11.12
High:2.86
Open:2.79
Low:2.67
Close:2.80
52wk High:3.11
52wk Low:1.05
Shares:195.00M
Float Shares:163.00M
Volume Ratio:0.68
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2535
EPS(LYR):-0.2325
ROE:-25.96%
ROA:-23.46%
PB:2.62
PE(LYR):-12.13

Loading ...

Press Release: Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

Dow Jones
·
Jun 03

LifeSci Capital Sticks to Its Buy Rating for Ovid Therapeutics (OVID)

TIPRANKS
·
May 16

B. Riley Securities Keeps Their Buy Rating on Ovid Therapeutics (OVID)

TIPRANKS
·
May 13

Analysts Are Bullish on Top Healthcare Stocks: Ovid Therapeutics (OVID), Imunon (IMNN)

TIPRANKS
·
May 13

Ovid Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Ovid Therapeutics Q1 net loss widens as R&D spending rises

Reuters
·
May 12

Ovid Therapeutics releases corporate presentation on neural hyperexcitability drug pipeline

Reuters
·
May 12

Ovid Therapeutics Q1 Operating Expenses USD 17.846 Million

THOMSON REUTERS
·
May 12

Ovid Therapeutics Q1 EPS USD -0.12

THOMSON REUTERS
·
May 12

Ovid Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 08

Ovid Therapeutics says Series A warrants expire after $53.9 million exercise

Reuters
·
Apr 20

Ovid Therapeutics (OVID) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Apr 20

Ovid Therapeutics to host KCC2 deep-dive R&D event on first-in-class activators

Reuters
·
Apr 08

Ovid Therapeutics (OVID) Gets a Buy from Wedbush

TIPRANKS
·
Apr 07

LifeSci Capital Sticks to Their Buy Rating for Ovid Therapeutics (OVID)

TIPRANKS
·
Mar 28

Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Ovid Therapeutics (OVID)

TIPRANKS
·
Mar 24

Regulatory Timing Risks Mount for Ovid Therapeutics as FDA Funding and Staffing Volatility Threaten Drug Approval Timelines

TIPRANKS
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies

Reuters
·
Mar 19

Exchange-Traded Funds, Equity Futures Lower Ahead of Key Economic Data, FOMC Meeting

MT Newswires Live
·
Mar 18

BUZZ-U.S. STOCKS ON THE MOVE-Tencent, Air Products, Protagonist

Reuters
·
Mar 18